Structure‐Based Prediction of QT Prolongation Risk Using Graph Neural Networks: An Integrative Approach Combining In Vitro hERG Assays and Pharmacovigilance Data

Documenti analoghi

• The Impact of QT‐Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case‐Crossover Study
  di: Hsiu‐Ting Chien, et al.
  Pubblicazione: (2024)
• Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes
  di: Ola Nordqvist, et al.
  Pubblicazione: (2025)
• Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation
  di: Emanuel Raschi, et al.
  Pubblicazione: (2025)
• Respiratory Disorders Associated with Antibody–Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases
  di: Victor Mirleau, et al.
  Pubblicazione: (2025)
• A Comment about AI Methods that May Help Advance Pharmacovigilance
  di: McKenna K. Anderson, et al.
  Pubblicazione: (2026)